Abstract
Recently, interest has grown in the use of androgen replacement therapy for postmenopausal women. Androgen replacement in women improves libido, bone density, and body composition. The adverse effects, like hirsutism, are generally mild, and the safety profile of transdermal testosterone replacement is more favorable than that of other modes of androgen therapy. Further studies may help to determine the effect of lipid changes on cardiac outcomes. We believe that long-term studies are necessary to observe the potential effect of androgen replacement on cardiovascular mortality, breast and endometrial tissues, and mood and anger before this therapy can be used routinely in women.
MeSH terms
-
Acne Vulgaris / chemically induced
-
Androgens / deficiency
-
Androgens / therapeutic use*
-
Breast Neoplasms / chemically induced
-
Cardiovascular Diseases / chemically induced
-
Cardiovascular Diseases / prevention & control
-
Chemical and Drug Induced Liver Injury
-
Contraindications
-
Counseling / methods*
-
Drug Monitoring
-
Endometrial Neoplasms / chemically induced
-
Female
-
Hirsutism / chemically induced
-
Hormone Replacement Therapy* / adverse effects
-
Hormone Replacement Therapy* / methods
-
Humans
-
Patient Education as Topic / methods*
-
Patient Selection
-
Postmenopause / drug effects*
-
Postmenopause / physiology
-
Safety Management / methods*
-
Time Factors
-
Treatment Outcome
-
Virilism / chemically induced
-
Women's Health